Groupama Asset Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$892K Buy
7,567
+130
+2% +$18.2K 0.01% 224
2025
Q4
$1.22M Buy
7,437
+5,903
+385% +$925K 0.02% 221
2025
Q3
$610K Sell
1,534
-3,656
-70% -$444K 0.01% 323
2025
Q2
$1.04M Hold
5,190
0.02% 272
2025
Q1
$1.1M Buy
5,190
+1,258
+32% +$194K 0.02% 241
2024
Q4
$976K Buy
3,932
+680
+21% +$97.5K 0.02% 276
2024
Q3
$389K Hold
3,252
0.01% 366
2024
Q2
$410K Hold
3,252
0.01% 383
2024
Q1
$598K Buy
3,252
+758
+30% +$144K 0.01% 367
2023
Q4
$449K Buy
+2,494
New +$388K 0.01% 346

Other funds holding RGEN

Groupama Asset Management's RGEN Position: Q1 2026 in Review

Groupama Asset Management increased its Repligen (RGEN) stake by 1.7% in Q1 2026, buying an estimated $18.2K and bringing the position to 7,567 shares worth $892K. The position accounts for 0.01% of the portfolio, ranked #224.

Groupama Asset Management first reported a position in RGEN in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.22M in Q4 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Groupama Asset Management held 7,567 shares of Repligen worth $892K as of Q1 2026.
  • Groupama Asset Management bought 130 Repligen shares in Q1 2026, an estimated $18.2K.
  • Repligen made up 0.01% of Groupama Asset Management's portfolio in Q1 2026, its #224 holding.
  • Groupama Asset Management first reported a position in Repligen in Q4 2023 and has held it in 10 quarters since.
  • Groupama Asset Management's Repligen position peaked at $1.22M in Q4 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Groupama Asset Management's 13F filing for Q1 2026, filed 22 May 2026.